يعرض 1 - 20 نتائج من 60 نتيجة بحث عن '"Active::Vaccination"', وقت الاستعلام: 0.54s تنقيح النتائج
  1. 1
    Book

    المساهمون: Departament de Salut

    المصدر: Scientia

    Time: 11, 16, 18

    وصف الملف: application/pdf

    Relation: Manual de vacunacions de Catalunya.; Vacuna anti-virus del papil·loma humà (vacuna VPH). A: Manual de vacunacions de Catalunya. Barcelona: Agència de Salut Pública de Catalunya; 2024. p.163-169.; https://hdl.handle.net/11351/11454

  2. 2
    Academic Journal

    المساهمون: Institut Català de la Salut, Mitsikostas DDD Neurology Department, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Caronna E, Pozo-Rosich P Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. De Tommaso M Neurophysiopathology Unit, DiBrain Department, Aldo Moro University, Bari, Italy. Deligianni CI Athens Naval Hospital, Athens, Greece. Ekizoglu E Istanbul Faculty of Medicine, Department of Neurology, Istanbul University, Istanbul, Turkey. Bolay H Department of Neurology and Algology, NÖROM, Gazi University Ankara, Ankara, Turkey, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: European Journal of Neurology;31(7); https://doi.org/10.1111/ene.16308; Mitsikostas DDD, Caronna E, De Tommaso M, Deligianni CI, Ekizoglu E, Bolay H, et al. Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S. Eur J Neurol. 2024 Jul;31(7):e16308.; https://hdl.handle.net/11351/11582; 001203428500001

  3. 3
    Academic Journal

    المساهمون: Institut Català de la Salut, Vincenzi B, Cortellini A, Mazzocca A, Orlando S, Romandini D Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus BioMedico, Roma, Italy. Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy. Aguilar-Company J, Ruiz-Camps I, Eremiev-Eremiev S Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Valverde Morales C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Therapeutic Advances in Medical Oncology;16; https://doi.org/10.1177/17588359231225028; Vincenzi B, Cortellini A, Mazzocca A, Orlando S, Romandini D, Aguilar-Company J, et al. Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry. Ther Adv Med Oncol. 2024 Jan 18;16:1–11.; https://hdl.handle.net/11351/11606; 001087480202650

  4. 4
    Academic Journal

    المساهمون: Institut Català de la Salut, Mitsikostas DDD Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece. Caronna E, Pozo-Rosich P Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. De Tommaso M Neurophysiopathology Unit, DiBrain Department, Aldo Moro University, Bari, Italy. Deligianni CI Athens Naval Hospital, Athens, Greece. Ekizoglu E Department of Neurology, Faculty of Medicine, Istanbul University, Istanbul, Istanbul, Turkey. Bolay H Department of Neurology and Algology, NÖROM, Gazi University Ankara, Ankara, Turkey, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: European Journal of Neurology;31(6); https://doi.org/10.1111/ene.16251; Mitsikostas DDD, Caronna E, De Tommaso M, Deligianni CI, Ekizoglu E, Bolay H, et al. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review. Eur J Neurol. 2024 Jun;31(6):e16251.; https://hdl.handle.net/11351/11481; 001174198400001

  5. 5
    Academic Journal

    المساهمون: Nomah DK, Aceiton J Centre Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya, Departament de Salut, Generalitat de Catalunya, Badalona, Spain. Institut d’Investigació Germans Trias i Pujol, Barcelona, Spain. Díaz Y, Moreno-Fornés S Centre Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya, Departament de Salut, Generalitat de Catalunya, Badalona, Spain. Institut d’Investigació Germans Trias i Pujol, Barcelona, Spain. CIBER Epidemiologia y Salud Pública, Barcelona, Spain. Bruguera A Centre Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya, Departament de Salut, Generalitat de Catalunya, Badalona, Spain. Institut d’Investigació Germans Trias i Pujol, Barcelona, Spain. CIBER Epidemiologia y Salud Pública, Barcelona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva i de Salut Publica, Universitat Autònoma de Barcelona, Bellaterra, Spain. Reyes-Urueña J Centre Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya, Departament de Salut, Generalitat de Catalunya, Badalona, Spain. Deig E Infectious Diseases Unit, Hospital General de Granollers, Granollers, Spain, Hospital General de Granollers

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Open Forum Infectious Diseases;11(1); https://doi.org/10.1093/ofid/ofad693; Nomah DK, Díaz Y, Bruguera A, Moreno-Fornés S, Aceiton J, Reyes-Urueña J, et al. Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis. Open Forum Infect Dis. 2024 Jan 5;11(1):ofad693.; https://hdl.handle.net/11351/11275

  6. 6
    Academic Journal

    المساهمون: Institut Català de la Salut, Favaro MTP Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil. Alamo P Institut de Recerca Sant Pau, Barcelona, (IR Sant Pau), Barcelona, Spain. Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain. CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN, ISCIII), Institut de Recerca Sant Pau, Barcelona, Spain. Roher N Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN, ISCIII), Institut de Recerca Sant Pau, Barcelona, Spain. Department of Cell Biology, Animal Physiology and Immunology, Universitat Autònoma de Barcelona, Bellaterra, Spain. Chillon M Department of Biochemistry and Molecular Biology, Institut de Neurociènces (INc), Universitat Autònoma de Barcelona, Bellaterra, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Unitat Producció de Vectors (UPV), Universitat Autònoma de Barcelona, Bellaterra, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Lascorz J Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN, ISCIII), Institut de Recerca Sant Pau, Barcelona, Spain. Márquez M Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: ACS Materials Letters;6(3); https://doi.org/10.1021/acsmaterialslett.3c01643; Favaro MTP, Alamo P, Roher N, Chillon M, Lascorz J, Márquez M, et al. Zinc-Assisted Microscale Granules Made of the SARS-CoV-2 Spike Protein Trigger Neutralizing, Antivirus Antibody Responses. ACS Mater Lett. 2024 Mar 4;6(3):954–62.; https://hdl.handle.net/11351/11199; 001166814100001

  7. 7
    Book
  8. 8
    Academic Journal

    المساهمون: Institut Català de la Salut, Ganem F Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva i de Salut Publica, Universitat Autònoma de Barcelona, Bellaterra, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Folch C Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. Colom-Cadena A, Bordas A Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Alonso L Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Fundació Lluita Contra les Infeccions, Badalona, Spain. Soriano-Arandes A Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Casabona J Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva i de Salut Publica, Universitat Autònoma de Barcelona, Bellaterra, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: PLoS ONE;18(3); https://doi.org/10.1371/journal.pone.0282871; Ganem F, Folch C, Colom-Cadena A, Bordas A, Alonso L, Soriano-Arandes A, et al. Determinants of COVID-19 vaccine hesitancy among students and parents in Sentinel Schools Network of Catalonia, Spain. PLoS One. 2023 Mar 9;18(3):e0282871.; https://hdl.handle.net/11351/9222

  9. 9
    Academic Journal

    المساهمون: Institut Català de la Salut, Carvajal R, Tur C, Bollo L, Rodriguez M, Pappolla A, Cobo-Calvo A, Carbonell P, Río J, Castilló J, Braga N, Mongay-Ochoa N, Vidal-Jordana Á, Arrambide G, Rodríguez-Acevedo B, Zabalza A, Midaglia L, Galán I, Comabella M, Sastre-Garriga J Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Martínez-Gómez X, Borras-Bemejo B, Rodrigo-Pendás JÁ Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Esperalba J Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. Montalban X, Tintoré M Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain. Otero-Romero S Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Multiple Sclerosis Journal;29(14); https://doi.org/10.1177/13524585231200303; info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01606; Carvajal R, Tur C, Martínez-Gómez X, Bollo L, Esperalba J, Rodriguez M, et al. A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients. Mult Scler. 2023 Dec;29(14):1841–8.; https://hdl.handle.net/11351/10720; 001069475500001

  10. 10
    Academic Journal

    المؤلفون: Plans-Rubió, Pedro

    المساهمون: Agència de Salut Pública de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Ciber of Epidemiology and Public Health (CIBERESP), Madrid, Spain, Departament de Salut

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Vaccines;11(12); https://doi.org/10.3390/vaccines11121836; Plans-Rubió P. Effectiveness of Adapted COVID-19 Vaccines and Ability to Establish Herd Immunity against Omicron BA.1 and BA4-5 Variants of SARS-CoV-2. Vaccines. 2023 Dec 10;11(12):1836.; https://hdl.handle.net/11351/10912

  11. 11
    Academic Journal

    المساهمون: Institut Català de la Salut, Otero-Romero S Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Lebrun-Frénay C CRCSEP Nice, CHU de Nice Pasteur, Universite ́ Nice Cote d’Azur UR2CA-URRIS, Nice, France. Reyes S Fundación Santa Fe de Bogotá, Bogotá, Colombia. School of Medicine, Universidad de los Andes, Bogotá, Colombia. Barts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK. Amato MP Department NEUROFARBA, University of Florence, Florence, Italy. IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy. Campins M Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Farez M Centro para la Investigación de Enfermedades Neuroinmunológicas (CIEN), FLENI, Buenos Aires, Argentina. Tintoré M Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: European Journal of Neurology;30(8); https://doi.org/10.1111/ene.15809; Otero-Romero S, Lebrun-Frénay C, Reyes S, Amato MP, Campins M, Farez M, et al. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. Eur J Neurol. 2023 Aug;30(8):2144–76.; https://hdl.handle.net/11351/10041

  12. 12
    Academic Journal

    المساهمون: Institut Català de la Salut, Hoff LS School of Medicine, Universidade Potiguar (UnP), Natal, Brazil. Ravichandran N Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. Shinjo SK, Junior JG Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil. Day J Department of Rheumatology, Royal Melbourne Hospital, Parkville, Australia. Walter and Eliza Hall Institute of Medical Research, Parkville, Australia. Department of Medical Biology, University of Melbourne, Parkville, Australia. Sen P Maulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, India. O'Callaghan AS Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Rheumatology International;43; https://doi.org/10.1007/s00296-022-05229-7; Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, et al. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Disease. Rheumatol Int. 2023 Jan;43:47–58.; https://hdl.handle.net/11351/8994; 000871168700001

  13. 13
    Academic Journal

    المساهمون: Institut Català de la Salut, Zamora JI, López-Martínez M, Patricio Liebana M, Leon Román JC, Bermejo S, Vergara A, Agraz I, Terrades NR, Azancot MA, Toapanta N, Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gabaldon MA Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Medicine;12(6); https://doi.org/10.3390/jcm12062420; info:eu-repo/grantAgreement/ES/PE2017-2020/PI17%2F00257; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI21%2F01292; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/RD21%2F0005%2F0016; Zamora JI, López-Martínez M, Patricio Liebana M, Leon Román JC, Bermejo S, Vergara A, et al. Epidemiology of Immune-Mediated Glomerulopathies before and after SARS-CoV-2 Vaccination: A Tertiary Referral Hospital Experience. J Clin Med. 2023 Mar;12(6):2420.; https://hdl.handle.net/11351/9298

  14. 14
    Academic Journal

    المساهمون: Álvaro-Gracia JM Rheumatology Department, Hospital General Universitario Gregorio Maranon, Madrid, Spain. Sanchez-Piedra C Spanish Agency of Health Technology Assessment, Instituto de Salud Carlos III, Madrid, Spain. Culqui D Research Unit, Spanish Society of Rheumatology, Madrid, Spain. Rosello R Rheumatology Department, Hospital General San Jorge, Huesca, Spain. Garcia-Dorta A Rheumatology Department, Hospital Universitario de Canarias, La Laguna, Spain. Campos C Rheumatology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain. Busquets N Rheumatology Department, Hospital General de Granollers, Granollers, Spain, Hospital General de Granollers

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: RMD Open;9(1); http://dx.doi.org/10.1136/rmdopen-2022-002936; Álvaro-Gracia JM, Sanchez-Piedra C, Culqui D, Rosello R, Garcia-Dorta A, Campos C, et al. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study. RMD Open. 2023 Mar;9(1):e002936.; https://hdl.handle.net/11351/9646

  15. 15
    Academic Journal

    المساهمون: Plans Rubió P Agència de Salut Pública de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Ciber of Epidemiology and Public Health (CIBERESP), Madrid, Spain. Jambrina AM, Rabanal M General Directorate for Healthcare Planning and Regulation, Department of Health of Catalonia, Barcelona, Spain. Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, Spain. Rius P Council of the Pharmacists' Association of Catalonia, Barcelona, Spain. Carmona G, Gironès M Agència de Salut Pública de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain, Departament de Salut

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Vaccines;10(12); https://doi.org/10.3390/vaccines10122140; Plans Rubió P, Jambrina AM, Rius P, Carmona G, Rabanal M, Gironès M. High Influenza Vaccine Effectiveness and Absence of Increased Influenza-like-Illness Epidemic Activity in the 2021-2022 Influenza Season in Catalonia (Spain) Based on Surveillance Data Collected by Sentinel Pharmacies. Vaccines. 2022 Dec 14;10(12):2140.; https://hdl.handle.net/11351/10910

  16. 16
    Academic Journal

    المساهمون: Institut Català de la Salut, Quiroga B IIS-La Princesa, Nephrology Department, Hospital Universitario de la Princesa, Madrid, Spain. Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Ortiz A IIS-Fundación Jiménez Diaz, School of Medicine, Universidad Autónoma de Madrid, Fundación Renal Iñigo Álvarez de Toledo-IRSIN, REDinREN, Instituto de Investigación Carlos III, Madrid, Spain. Jaravaca Mantecón CJ, Nava Pérez N Diaverum Andalucía, Spain. Serra Martín M Diaverum Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Clinical Kidney Journal;15(10); https://doi.org/10.1093/ckj/sfac169; Quiroga B, Soler MJ, Ortiz A, Jaravaca Mantecón CJ, Nava Pérez N, Serra Martín M, et al. Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study. Clin Kidney J. 2022 Oct;15(10):1856–64.; https://hdl.handle.net/11351/8476; 000844260500001

  17. 17
    Academic Journal

    المساهمون: Institut Català de la Salut, Parés-Badell O, Zules-Oña R, Pinós L, Vivet-Escalé M Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca d’Epidemiologia i Salut Pública, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Armadans L, Borrás-Bermejo B, Otero S, Rodrigo-Pendás JÁ, Martínez-Gómez X Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca d’Epidemiologia i Salut Pública, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Unitat Docent, Universitat Autònoma de Barcelona, Bellaterra, Spain. Cossio-Gil Y Unitat de Suport a la Decisió, Direcció de Sistemes d’Informació, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Gestió del Sistema Sanitari, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Agustí A Servei de Farmacologia Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Aguilera C Servei de Farmacologia Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Campins M Grup de Recerca d’Epidemiologia i Salut Pública, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Vaccines;10(8); https://doi.org/10.3390/vaccines10081217; Parés-Badell O, Zules-Oña R, Armadans L, Pinós L, Borrás-Bermejo B, Otero S, et al. Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination. Vaccines. 2022 Jul 29;10(8):1217.; https://hdl.handle.net/11351/8403; 000845137300001

  18. 18
    Academic Journal

    المساهمون: Institut Català de la Salut, Gil-Vila A, Selva-O'Callaghan A Unitat d’Inflamació i Autoimmunitat, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Ravichandran N Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. Sen P Maulana Azad Medical College, Delhi, India. Nune A Southport and Ormskirk Hospital NHS Trust, Southport, UK. Gaur PS Smt. Kashibai Navale Medical and General Hospital, Pune, India, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Muscle & Nerve;66(4); https://doi.org/10.1002/mus.27681; Gil-Vila A, Ravichandran N, Selva-O’Callaghan A, Sen P, Nune A, Gaur PS, et al. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies. Muscle Nerve. 2022 Oct;66(4):426–37.; https://hdl.handle.net/11351/8465; 000851481600001

  19. 19
    Academic Journal

    المساهمون: Ferreiro-Iglesias R Servicio de Gastroenterología, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain. Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, A Coruña, Spain. Piqueras M Servei de Gastroenterologia, Hospital de Terrassa, Consorci Sanitari de Terrassa (CST), Terrassa, Spain. Ricart E Servicio de Gastroenterología, Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain. Sempere L Servicio de Gastroenterología, Hospital General Universitario de Alicante, Alicante, Spain. Roca M Servei de Farmàcia, Hospital de Terrassa, Consorci Sanitari de Terrassa (CST), Terrassa, Spain. Martín de Carpi J Unidad para el Cuidado Integral de la Enfermedad Inflamatoria Intestinal Pediátrica (UCIEII-P), Servicio de Gastroenterología, Hepatología y Nutrición Pediátrica, Hospital Sant Joan de Déu, Barcelona, Spain, Consorci Sanitari de Terrassa

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Gastroenterología y Hepatología;45(10); https://doi.org/10.1016/j.gastrohep.2022.03.012; Ferreiro-Iglesias R, Piqueras M, Ricart E, Sempere L, Roca M, Martín de Carpi J, et al. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre la importancia, el cribado y la vacunación en pacientes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol. 2022 dic;45(10):805-18.; https://hdl.handle.net/11351/9534

  20. 20
    Book